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Abstract
Background: As a first step to explore the possible relationships existing between the effects of
low oxygen pressure in the first trimester placenta and placental pathologies developing from mid-
gestation, two subtracted libraries totaling 2304 cDNA clones were constructed. For achieving
this, two reciprocal suppressive/subtractive hybridization procedures (SSH) were applied to early
(11 weeks) human placental villi after incubation either in normoxic or in hypoxic conditions. The
clones from both libraries (1440 hypoxia-specific and 864 normoxia-specific) were spotted on
nylon macroarrays. Complex cDNAs probes prepared from placental villi (either from early
pregnancy, after hypoxic or normoxic culture conditions, or near term for controls or pathological
placentas) were hybridized to the membranes.
Results:  Three hundred and fifty nine clones presenting a hybridization signal above the
background were sequenced and shown to correspond to 276 different genes. Nine of these genes
are mitochondrial, while 267 are nuclear. Specific expression profiles characteristic of preeclampsia
(PE) could be identified, as well as profiles specific of intra-uterine growth retardation (IUGR).
Focusing on the chromosomal distribution of the fraction of genes that responded in at least one
hybridization experiment, we could observe a highly significant chromosomal clustering of 54 genes
into 8 chromosomal regions, four of which containing imprinted genes. Comparative mapping data
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indicate that these imprinted clusters are maintained in synteny in mice, and apparently in cattle
and pigs, suggesting that the maintenance of such syntenies is requested for achieving a normal
placental physiology in eutherian mammals.
Conclusion: We could demonstrate that genes induced in PE were also genes highly expressed
under hypoxic conditions (P = 5.10-5), which was not the case for isolated IUGR. Highly expressed
placental genes may be in syntenies conserved interspecifically, suggesting that the maintenance of
such clusters is requested for achieving a normal placental physiology in eutherian mammals.
Background
Preeclampsia (PE) is a severe disorder of human pregnan-
cies affecting up to 10 % of primiparous women in indus-
trialized countries. This hypertensive disease develops
from the second half of pregnancy and is associated with
proteinuria, and sometimes with oedemas. The causes of
preeclampsia are complex and multiple, with a combina-
tion of environmental and genetic effects from maternal
[1] as well as paternal origin [2,3]. At the histological
level, preeclampsia is characterized by a shallow coloniza-
tion of the maternal endometrium (and more specifically
of the wall of the uterine vessels) by the invasive cytotro-
phoblasts. In a normal gestation, this process occurs dur-
ing the second trophoblastic colonization wave around
the end of the first trimester of gestation allowing the
invasive cytotrophoblasts to reach the placental bed. In
this case, the arterial wall is infiltrated by endovascular
trophoblasts, triggering a suppression of the vasomotor
control, thus resulting in a very important dilatation of
the lumen and a loss of the elastic properties of the arteries
[4-8]. By contrast, when the invasion is defective, remain-
ing too shallow [9], fibrinous material accumulates in the
arteries, myocytes proliferate. This may lead to local
thrombosis and is therefore supposed to impact on the
local oxygen pressure leading to placental ischemia/
hypoxia, and ultimately to functional anomalies of the
maternal vascular endothelium [10,11]. Finally, the func-
tions of the syncytiotrophoblast, the specific tissue result-
ing from the fusion of the cytotrophoblasts, may be
modified, leading to trophoblast apoptosis. Links
between placental pathology and hypoxia are now clearly
documented ([12,13], for a recent review, see Challier et
Uzan, 2003; [14]). Intra-Uterine Growth Retardation
(IUGR) constitutes another group of complex diseases, a
large subset of which is associated with placental malfunc-
tion, and often with preeclampsia, although this is not at
all systematic. IUGR may be defined as a rupture in the
normal growth curve of the foetus, although it is generally
defined as a birth weight inferior to the 10th or to the 3rd
percentile (according to a chosen arbitrary limit) of the
smallest babies. This simple definition does not take into
account the dynamics of the growth curve, but is very eas-
ily workable. This explains at least partly the underlying
complexity present under the term IUGR. At least, two
very distinct situations are possible: IUGR may be the
result of endogenous developmental and growth factors
affecting the fetus growth; or, alternatively, a placental
defect may inhibit the transfer of nutriments and oxygen
from the mother to the fetus (IUGR of vascular origin or
not). In the following, vascular IUGR correspond to those
exhibiting an abnormal Doppler. In this latter case, the
IUGR may be caused by a vascular pathology such as PE.
Consequently, there is a clear need for classification of
IUGR, and for improving the understanding of its etiol-
ogy, both issues possibly based upon the characterization
of specific marker genes.
In addition, it is now well documented that babies pre-
senting with a small birth weight are at increased risk for
developing systemic pathologies at adulthood, such as
diabetes or cardiovascular troubles [15,16]. One clear lim-
itation of the therapeutic possibilities for PE and IUGR
resides in the fact that whilst many indications suggest
that their causes are very precocious during placental
development [17], their symptoms occur late, at least
from mid-gestation, and more often from the last trimes-
ter of the pregnancy. Evaluating the risk early would allow
orienting the medical choices towards a better follow-up
of the pregnancy, or even towards some pharmacological
options, such as the chronic use of mild doses of aspirin.
In order to explore on a wide basis the links between
hypoxia and placental diseases, and to identify early puta-
tive markers of the preeclamptic pathology, we combined
the Subtractive/Suppressive Hybridization (SSH) meth-
odology starting with cDNA material obtained from first
trimester placental purified villi with the construction of
high-density nylon macroarrays (Figure 1). A first charac-
terization of the libraries has previously been performed
by systematic sequencing, enabling to identify all the
genes that were modulated by short-term hypoxia in early
placental villi, even when this genes are expressed at a low
level [18]. However, this systematic sequencing approach
does not indicate which gene could constitute an optimal
early marker for disease detection (highly and differen-
tially expressed). Therefore, in the present study, we used
the less sensitive approach of hybridization in order to
identify genes modulated early by hypoxia in pregnancy
(the end of first trimester, which is crucial for trophoblast
invasion), and also highly expressed and modified inBMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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placental diseases occurring later. We report here on the
macroarray hybridization results obtained from 20 differ-
ent sources of cDNA. We demonstrate a clear association
between PE and the early hypoxic induction of a series of
genes involved in different metabolic processes. This asso-
ciation was totally absent when cDNAs from isolated
IUGR were used as probes. We could also demonstrate
that the kinetics of hypoxia is not linear, and that genes
transcriptionnally modulated in early placentas after 3 h
of hypoxia may return to their basal expression level when
the culture is maintained for 48 h in hypoxic conditions.
Finally, we demonstrate that genes highly expressed in the
placenta are clustered in specific chromosome regions, in
particular in regions previously defined as containing
imprinted genes, such as 11p15.5.
Results
1. Overview of the genes highly expressed in placental 
physiology according to their putative interactions
When all the hybridizations were considered, 641 clones
out of 2304 yielded a response above the background
level of the membrane after an overnight autoradiogra-
phy. Hybridization with a labeled Oligo dT indicated that
281 clones corresponded to Oligo dT sequences cloned
A chart presenting the protocol used to construct the principal tool used in this study: high density nylon membranes spotted  with two Suppressive Subtractive Hybridization libraries (SSH) Figure 1
A chart presenting the protocol used to construct the principal tool used in this study: high density nylon membranes spotted 
with two Suppressive Subtractive Hybridization libraries (SSH). The original cDNAs were obtained from 11-weeks placental 
villi maintained in normoxia or hypoxia. Two reciprocally subtracted libraries were constructed and spotted at high density on 
nylon membranes. Then hybridizations were carried out using complex probes from various placentas (either from healthy, or 
from pathological pregnancies). The rationale of using early villi and hybridizing with near-term villi was the aim of identifying 
genes modified early by hypoxia, and still modified later chronically in the pathological state.
Placenta 11 weeks
SSH
Hybridizations
Systematic sequencing
•cDNA from early placental villi
•Native
•Hypoxic
•cDNA from Healthy term placentas
•cDNA from pathologic « term »
placentas
Biomarkers Physiopathology
Nylon Macroarrays
Hypoxia Normoxia
Placental villi in normoxia Pp02 = 21% Placental villi in hypoxia Pp02 = 2%BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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during the SSH procedure. These clones were generally
highly labeled in most hybridization experiments, except
when the probe was prepared from a placenta where the
apparent level of transcriptional activity was dramatically
decreased (i.e. vascular IUGR, see below). Finally, 360
sequences corresponded to known genes of which 276
were different (9 mitochondrial and 267 nuclear genes).
The normalization effect of the SSH was demonstrated by
the fact that 243 genes were found only once. The most
frequent was CGA (corresponding to the common alpha
chain of four glycoprotein hormones, LH, FSH, TSH and
hCG), found in 9 occurrences. The other frequently repre-
sented genes corresponded to mitochondrial genes
involved in the structure of the mitochondrial ribosome
(16S, 6 occurrences, and 12S, 4 occurrences) or in the res-
piratory chain (COX1, 4 occurrences, COX3, 3 occur-
rences). The complete set of genes could be divided in 11
distinct cell functions: RNA binding, Protein synthesis,
Apoptosis, Inflammation, Cell to Cell contacts, Angiogen-
esis, Epigenetic mechanisms and Imprinting, Cytoskele-
Putative physiological relationships between nuclear genes found expressed at a detectable level on the membranes Figure 2
Putative physiological relationships between nuclear genes found expressed at a detectable level on the membranes. Amongst 
a total of 269 nuclear genes, known described relationships could be deduced from the literature for 117 of them. The genes 
were grouped in 11 categories. In blue and red are represented genes transcriptionnally inhibited or activated by hypoxia, 
respectively. In green are presented genes that were not detected by hybridization but that may play critical roles in placental 
physiology. Open boxes present the main physiological action of several of these genes. Arrows indicate an activation effect, 
while lines terminated by circles indicates an inhibitory effect. Lines terminated by two circles are indicative of a physical inter-
action between two protein products, or between a protein and a RNA molecule. Table 5 (supplemental table) gives the com-
plete name of the genes displayed on the figure.BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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ton constitution, Signal transduction, Cell cycle and Lipid
metabolism. These functions and the links existing
between 117 genes are represented in Figure 2, drawn
from literature information. Genes induced by hypoxia
are written in red and genes inhibited by hypoxia in blue.
Amongst several noticeable features, the picture exhibits a
large amount of genes encoding RNA-interacting factors.
Several of these genes encode proteins recognizing specific
mRNAs. This is the case for NUFIP1 that interacts specifi-
cally with EEF1A1 mRNA, this latter encoding a specific
elongation factor interacting with ribosomal proteins for
elongating nascent polypetidic chain. Similarly, IGFII
(Insulin-like Growth Factor II) mRNA Binding Protein-3
(IMP-3), interacts in particular with IGFII mRNA [19], a
well known very important actor of placental growth and
physiology, as demonstrated recently by the specific inval-
idation of the IGFII placental isoform [20]. The impor-
tance of IMP3 was recently emphasized in a study
demonstrating by RNA interference its involvement for
enhancing IGFII mRNA translation in K562 leukemia cells
[21]. RNA interacting factors represent less than 1% of the
total gene content in mammals. In our subset of highly
expressed placental genes, they represent over 4% of the
total.
2. Hierarchical clustering of genes and hybridization 
experiments
To take into account the complexity of the tissue, the
hybridization experiments were grouped into six catego-
ries from the cDNA prepared from samples listed in Table
1. The signals from the different experiments were aver-
aged, as described in Experimental Procedures. The clus-
tering tool developed by Eisen and coworkers [22] was
applied to the set of 360 identified genes. Two hundred
and seventy five genes could be grouped in seven clusters
of similar expression (A to G, figure 3 and 4). The experi-
ments were classified by the program in the following
organization: normal placenta, either term or early were
grouped into one cluster while placenta from disease
states or from villi maintained in hypoxia during 48 h
Table 1: Status of the patients used in the study
Patient Status RT (*) Weeks 
Amenhorrhea
Year 
mother
HTA (**) Proteinuri
a g/24 h
Uterine 
Doppler 
(****)
Oligoamnios Apgar 1 Apgar 5 SEX Birthweight in g 
(Percentile)
3008 Term 
(control)
784 38+4 32 normal normal normal normal 10 10 M 3050
7497 Term 
(control)
816 38+0 34 normal normal normal normal 10 10 M 3270
497 Term 
(control)
817 40+5 35 normal normal normal normal 10 10 M 3040
3007 Term 
(control)
818 38+4 43 normal normal normal normal 10 10 M 3430
3011 Term 
(control)
819 38+0 37 normal normal normal normal 10 10 M 3710
3013 Term 
(control)
820 39+4 42 normal normal normal normal 10 10 F 2740
3017 Term 
(control)
821 38+5 41 normal normal normal normal 10 10 F 3110
3004 PE 765 28+5 34 205/120 10,69 normal normal 2 8 M 830
3005 PE 766 37+4 45 140/90 0,17 Unilateral normal 10 10 F 2930
225 PE 807 27+0 24 145/90 2,7 normal normal 9 10 M 1080
242 PE 867 33+1 26 150/95 5,36 normal normal 8 10 M 1960
3010 PE 808 32+5 36 160/110 14,36 normal normal 10 10 M 1196
50 PE 885 30+0 22 175/105 8,68 normal normal 8 10 M 1390
4003 PE+IUGR 915 34+1 36 180/120 2,1 normal amniotic fluid 
in excess
0 7 F 1670 (< 5)
3012 PE+IUGR 770 34+1 37 140/90 6,98 normal unknown 9 10 F 1800 
(between 5 and 10)
3016 PE+IUGR 772 28+0 37 160/100 nc bilateral Abnormal 7 10 M 780 (< 5)
3003 vascular 
IUGR
773 37+3 26 160/90 normal bilateral unknown 10 10 M 1890 
(between 5 and 10)
3021 vascular 
IUGR
810 31+3 35 normal normal bilateral Abnormal 7 10 M 1380 
(> 10 but ***)
3022 vascular 
IUGR
814 37+0 33 normal normal unknown Abnormal 3 9 M 2330 
(between 5 and 10)
* RT: reversed transcribed RNA sample
** HTA: Arterial Hypertension
*** IUGR defined bya break in the intrauterine growth curve, a bilateral doppler associated with an absence of diastolic pressure
**** Presence of a doppler signal in one or both the umbilical arteriesBMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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were grouped in another cluster. In a lower order cluster,
PE and PER were grouped and associated with early villi
maintained during 48 h in hypoxia while isolated IUGR
was placed separately. The distribution of genes into two
sets (hypoxia-induced versus hypoxia-inhibited) made it
possible to assess statistically the possible relationships
between the effects on the transcript levels of a relatively
short period of hypoxia (3 h) on early placenta (the
hypoxic condition that was used to construct the arrays)
and pathological states developing later (Table 2). Genes
that are specific of the placenta, either early or at term,
have a slight trend to be specifically induced by hypoxia
in early term placenta. There is also a highly significant
tendency of preeclamptic villi, either from isolated PE or
PE combined with IUGR, to express genes induced by 3 h
hypoxia in early placental villi. The inverted trend is
observed at a highly significant level in hybridizations car-
ried out with probes obtained from early term villi main-
tained in hypoxia during 48 h with an excess of
"normoxic" genes found in this situation. We supposed
that this observation could be related to a specific kinetics
of induction by oxygen concentration, where short expo-
sure to hypoxia may have effects that are at the opposite
of long-term hypoxia. Indeed, we could observe that genes
Pictures obtained after data clustering of the SSH hybridizations using the Treeview software [22] Figure 3
Pictures obtained after data clustering of the SSH hybridizations using the Treeview software [22]. The programs were used 
according to the parameters described in Material and Methods. Clusters of genes expressed in specific situations are repre-
sented. Above the general tree are presented the means of the different hybidization grouped into 6 categories of probes used. 
Clusters of transcriptionnally induced genes could be characterized. A, Full Term Placentas (Mean FTP); B, Early Term Placen-
tas (Mean ETP), C, Preeclampsia with IUGR (mean PER); D, PER + isolated PE; E, isolated IUGR (Mean R), F, isolated PE (Mean 
PE), G, 48 h hypoxia.BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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whose expression was modified by short periods of
hypoxia may later return to their basal expression level as
shown by analyzing kinetics of expression in hybridiza-
tions with cDNA of the same placenta maintained in
hypoxia during 3, 24 or 48 hours (Figure 5). In the cases
of isolated vascular IUGR, due to a drastic limitation of
the materno-foetal blood flow only 40 positive clones
yielded a detectable signal (instead of 400–500 when
other probes were hybridized to the membranes, includ-
ing the polyA containing clones). These positive clones
corresponded to mitochondrial genes, IGFII and PSG4,
PSG5, and PSG7 (Pregnancy Specific Glycoproteins 4, 5
and 7), indicating that these genes constitute a minimal
survival set to sustain gestation. Moreover, the signal level
of positive clones was quite comparable with that of other
experiments, demonstrating that the relevant RNA species
are indeed present at a high level. Since transcriptional
activity is very reduced in vascular IUGR (as shown by the
very low abundance of polyA+ RNAs), this suggests that
some mRNA molecules are specifically protected from
degradation in the very harsh pathological condition of
vascular IUGR.
Pictures obtained after data clustering of the SSH hybridizations using the Treeview software [22] Figure 4
Pictures obtained after data clustering of the SSH hybridizations using the Treeview software [22]. The programs were used 
according to the parameters described in Material and Methods. Clusters of genes expressed in specific situations are repre-
sented. Above the general tree are presented the means of the different hybidization grouped into 6 categories of probes used. 
Clusters of transcriptionnally induced genes could be characterized. A, Full Term Placentas (Mean FTP); B, Early Term Placen-
tas (Mean ETP), C, Preeclampsia with IUGR (mean PER); D, PER + isolated PE; E, isolated IUGR (Mean R), F, isolated PE (Mean 
PE), G, 48 h hypoxia.BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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Kinetics of hypoxia regulation in early (11 weeks) placentas Figure 5
Kinetics of hypoxia regulation in early (11 weeks) placentas. Six examples of genes exhibiting a transcriptional arrest under 
short hypoxic conditions, but coming back to almost normal levels of expression under extended hypoxic conditions.
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3. Identification of factors specific of the pathological 
status of the placenta
Table 3 was extracted from the database using PE as a key-
word in the field "Maximal signal". It contains 56 differ-
ent genes, amongst a total of 71. Among these genes,
some were observed in only one PE case (27), while some
others were observed in several or all the hybridizations
with probes obtained from PE (29 signals), 6 in PE
+IUGR, 6 only in the case of a severe PE that was used in
the hybridization (clinically defined as an arterial hyper-
tension exceeding 160 mm Hg), while the 3 left could also
be observed at a high level in normal term placentas. The
set of genes highly expressed in more than one PE consti-
tutes of course a collection of natural candidates for a fur-
ther exploration of the pathology. These 17 genes are:
ACTG1,  ATP5B,  ATP6,  ANGPTL4,  CGA,  COX1,  COX3,
CSHL1 (human Placental lactogen), GAPDH, FLJ22728,
H19, ND1, ND3, NUFIP1, PSG5, PSG7 and RPL41. Some
of these genes, such as CSHL1 have already been identi-
fied as PE markers [23,24]. Some others such as
ANGPTL4, COX1, FLJ22728, H19 and NUFIP1 are com-
pletely new candidates. There were 22 signals
corresponding to genes highly elevated in IUGR
corresponding to 20 different factors, 15 of which were
not correlated with PE (Table 4).
4. Promoter structure of PE/Hypoxia induced genes
Sequences spanning from 5000 bp of DNA 5' of the tran-
scription start site and extending 200 bp after, were recov-
ered from GenBank at the NCBI and were analysed for
their composition in CpG islands and the presence or
absence of Hypoxia Inducible Factor 1 α (HIF1α) binding
sites. HIF is a transcription factor protected from degrada-
tion in many cell system under hypoxic conditions. It
plays an essential role in modulating responses to hypoxia
by inducing or inhibiting multiple genes. Four possible
binding sites have been described for this factor,
ACGTGC, ACGTGG, GCGTGC and GCGTGG [25].
The promoters could be classified into four categories:
Several of them, such as the promoters of PSG4, 5 or 7,
CUL4, or CGA, do not contain any noticeable CpG
islands. Several others contain a concentration of CpG
islands very close to, or encompassing the transcription
start site (PAPOLA, WBSCR1, COTL1, SMARCC1). Other
promoters contain CpG islands at around 2000 bp 5'
upstream of the ATG (FEM1C, FLJ11149). Finally, some
promoters are highly enriched in CpG islands over the
whole 5000 bp examined (ACTG1, IGFII, H19). The set of
promoters with the CpG density and the position of puta-
tive HIF binding sites are supplied as Supplemental data
file 1. We could also classify these promoters according to
the maximal density of CpG achieved in the 5 kb window
analysed in five groups (less than 50, from 50 to 100, 100
to 150, 150 to 200 and more than 200). Consistently with
the high GC-richness of putative HIF binding site, there
was a clear linear relationship between the CpG density
and the number of putative HIF binding sites (R2 = 0.86).
The distribution of these sites was analysed inside the pro-
moters by sharing these promoters into two halves of
equal length and counting the putative sites inside each
subsequence. A student T-test did not reveal any prefer-
ence towards one side against the other (P = 0.45).
Table 2: Statistics of gene induction under various conditions
Category Normoxia (plates 1–9) Hypoxia (plates 10–24) Chi2 Observations
A Full-Term Placenta Observed 12 26
Expected 14,25 23,75 0,451 38
B Early+Full-Term Placenta Observed 9 31
Expected 15 25 0,050 40
C PE+RCIU Observed 9 37
Expected 17,25 28,75 0,012 46
D PE+RCIU and isolated PE Observed 10 10
Expected 7,5 12,5 0,248 20
E RCIU Observed 6 9
Expected 5,625 9,375 0,841 15
F Isolated PE Observed 2 35
Expected 13,875 23,125 0,000 37
G Early Term Placenta Hypoxia 48 h Observed 45 36
Expected 30,375 50,625 0,001 81
Each category (A-G) corresponds to a cluster of genes observed in figure 3 (a-b). The expected values were calculated from the proportion of 
clones in each subtracted library. Significant Chi2 values are represented in bold charactersBMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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Table 3: Genes induced in PE
Gene symbol Gene name Maximal signal Protein category Chromosomal 
localization
Library 
address
16S ribosomal RNA 16S ribosomal RNA one PE case Transcription/Translation Mitochondrie 18B8
16S ribosomal RNA 16S ribosomal RNA PE+IUGR Mitochondrial metabolism Mitochondrie 14H2
18S rRNA ARN 18S severe PE Transcription/Translation 13F12
ACTG1 actin, gamma 1 several PE Structure protein 17q25 22G1
angiopoietin-like 4 ANGPTL4 = PPARG angiopoietin related 
protein
several PE Transcription/Translation 19p13.3 11D9
ATP5B ATP synthase, H+ transporting, mitochondrial 
F1 complex, beta polypeptide
several PE Mitochondrial metabolism 12p13-qter 11A4
ATP6 ATP synthase F0 subunit 6 several PE Mitochondrial metabolism Mitochondrie 16D7
C9orf90 chromosome 9 open reading frame 90 
DKFZp762G199
one PE case 9q34.13 2C10
CDC37 CDC37 cell division cycle 37 homolog (S. 
cerevisiae)
several PE Cell cycle 19p13.2 10E10
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 23B10
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 2C5
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 23D12
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 10H5
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 2H4
CGA glycoprotein hormones, alpha polypeptide several PE Signal transduction 6q12-21 16D5
CGA glycoprotein hormones, alpha polypeptide Terms/PE Signal transduction 6q12-21 8B8
COX1 Cytochrome c oxidase subunit I several PE Mitochondrial metabolism Mitochondrie 13H7
COX1 Cytochrome c oxidase subunit I several PE Mitochondrial metabolism Mitochondrie 15B3
COX1 Cytochrome c oxidase subunit I several PE Mitochondrial metabolism Mitochondrie 12H9
COX1 Cytochrome c oxidase subunit I several PE Mitochondrial metabolism Mitochondrie 18D6
COX2 Cytochrome c oxidase subunit II one PE case Mitochondrial metabolism Mitochondrie 8B7
COX3 Cytochrome c oxidase subunit III several PE Mitochondrial metabolism Mitochondrie 20F4
CSHL1 chorionic somatomammotropin hormone-like 1 several PE Signal transduction 17q24.2 19A7
CSNK1A1 Casein kinase 1, alpha 1 one PE case Signal transduction 5q32 18A8
DDX3X DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-
linked
one PE case Transcription/Translation/
Modifi
p11.3-11.23 17F11
DKFZP434F2021 DKFZP434F2021 protein one PE case 3q13.2 6A3
DKFZp586F1223 Hs.28540 severe PE 11q23 20F7
EEF1A1 eukaryotic translation elongation factor 1 alpha 1 one PE case Transcription/Translation 6q14.1 7A11
EIF4B eukaryotic translation initiation factor 4B one PE case Transcription/Translation 12q13.13 2C7
ERVWE1 endogenous retroviral family W, env(C7), 
member 1 (syncytin)
one PE case Cell-cell contacts 7q21-22 8G1
FEM1C fem-1 homolog c (C.elegans) PE+IUGR Transcription/Translation 5q22 16D6
FEM1C fem-1 homolog c (C.elegans) PE+IUGR Transcription/Translation 5q22 8D9
FLJ11149 riboflavin kinase one PE case Transport 9q21.31 23F12
FLJ22728 hypothetical protein FLJ22728 DKFZp761I1913 several PE Transport 11p15.2 23G6
FLJ22728 hypothetical protein FLJ22728 DKFZp761I1913 several PE Transport 11p15.2 23B6
GAPD glyceraldehyde-3-phosphate dehydrogenase several PE Mitochondrial metabolism 12p13 23D3
GAPD glyceraldehyde-3-phosphate dehydrogenase several PE Mitochondrial metabolism 12p13 24B3
GLIPR1 GLI pathogenesis-related 1 (glioma) PE+IUGR 12q21.1 16G10
H19 H19, imprinted maternally expressed 
untranslated mRNA
several PE RNA gene 11p15.5 18C1
H3F3B H3 histone, family 3B (H3.3B) severe PE Chromatin structure 17q25 11C8
IL8 interleukin 8 severe PE Apoptose regulation 4q13-q21 12G11
ITGAV integrin, alpha V (vitronectin receptor, alpha 
polypeptide, antigen CD51)
one PE case Cell-cell contacts 2q31-32 11B11
LAMA5 laminin, alpha 5 one PE case Apoptose regulation 20q13.2-13.3 1C3
LOC126731 LOC126731 Terms/PE 1q42.13 24F2
LOC374933 Homo sapiens LOC374933 (LOC374933), PE+IUGR 1p36.33 21G10
MAN1 integral inner nuclear membrane protein one PE case Transcription/Translation/
Modifi
12q14 7A7
MATR3 Matrin 3 severe PE Transcription/Translation/
Modifi
5q31.3 3C8
MGC2714 hypothetical protein MGC2714 PE+IUGR 11q22.2 13C7
ND1 NADH dehydrogenase subunit 1 several PE Mitochondrial metabolism Mitochondrie 12C4BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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5. Non-random chromosome distribution of placental 
genes in eutherian mammals
The analysis of the cytogenetic location available from our
database revealed that several genes expressed at a detect-
able level in hybridization experiments were clustered to
specific chromosomal regions. We focused our interest on
the precise chromosome location of these genes, using the
information available at the NCBI site [26] in order to
obtain their precise physical position expressed in
megabases.
We could confirm by statistical analysis (see Experimental
Procedures) that the distribution of the subset of highly
expressed placental genes was not random. On the con-
trary, we identified 8 clusters on 7 different chromosome
regions: 1p36 (9.76 Mb), 6q14 (0.23 Mb), 11p15 (11.63
Mb), 11q13 (16.28 Mb), 12q13 (3.65 Mb), 19q13 (12.35
Mb), 20q13 (15.11 Mb) and Xq24 (7.45 Mb) (Figure 6).
Among these regions, 4 are known to contain imprinted
genes (1p36, 11p15, 19q13 and 20q13). These four
regions are conserved in synteny and colinearity in mice,
while the regions corresponding to human 11q13 and
12q13 are separated on different mice chromosomes.
Despite the more limited mapping information available
in pigs, obtained at the Iccare website [27] and cattle
[28,29], we did not detect any chromosome breakpoints
in these species for these specific chromosome regions.
Discussion
In this study we designed a new transcriptome resource
directed at evaluating the effects of hypoxia on human
placenta. This tool is particularly original if compared to
the existing commercial membranes, since the distribu-
tion of clones into two subgroups makes it possible to
analyze statistically whether one condition is connected
to hypoxia-induced stimulation or inhibition of gene
expression. This was clearly shown for PE, a pathologic
condition that correlated very well with the induction of
"hypoxic" genes. Since the placenta is one of the organs
presenting the greatest abundance of diversified tran-
ND3 NADH dehydrogenase subunit 3 several PE Mitochondrial metabolism Mitochondrie 18H7
NRCAM neuronal cell adhesion molecule one PE case Cell-cell contacts 7q31.1-q31.2 18F11
NUFIP1 nuclear fragile × mental retardation protein 
interacting protein 1
several PE RNA-interacting factor 13q14 4E6
OSBPL2 oxysterol binding protein-like 2 one PE case Signal transduction 20q13.3 1C3
PSG4 pregnancy specific beta-1-glycoprotein 4 one PE case Signal transduction 19q13.2 16C9
PSG4 pregnancy specific beta-1-glycoprotein 4 one PE case Signal transduction 19q13.2 11A9
PSG5 pregnancy specific beta-1-glycoprotein 5 several PE Signal transduction 19q13.2 10F12
PSG7 pregnancy specific beta-1-glycoprotein 7 several PE Signal transduction 19q13.2 10C11
PSG7 pregnancy specific beta-1-glycoprotein 7 several PE Signal transduction 19q13.2 16F9
RPL41 ribosomal protein L41 several PE Transcription/Translation/
Modifi
12q13 18B9
RPS11 ribosomal protein S11 one PE case Transcription/Translation/
Modifi
19q13.3 13C9
RPS24 ribosomal protein S24 one PE case Transcription/Translation/
Modifi
10q22-23 4C8
RPS6KC1 ribosomal protein S6 kinase, 52kDa, polypeptide 
1
severe PE Transcription/Translation/
Modifi
1q41 10C8
rRNA 28S Human 28S ribosomal RNA gene one PE case RNA gene 8q21.1-q21.2 6G8
S100P S100 calcium binding protein P one PE case Cell cycle 4p16 5D3
SMARCC1 SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily c, 
member 1
one PE case Structure de la chromatine 3p23-21 8A2
SRP9 signal recognition particle 9kDa one PE case Transport 1q42.13 5E10
UCP2 uncoupling protein 2 (mitochondrial, proton 
carrier)
one PE case Mitochondrial metabolism 11q13 8C3
VIM vimentin one PE case Structural protein 10p13 5H2
WBSCR1 Williams-Beuren syndrome chromosome region 
1 EIF4H
one PE case Transcription/Translation/
Modifi
7q11.23 14E4
WBSCR16 Williams-Beuren syndrome chromosome region 
16
one PE case Transcription/Translation/
Modifi
7q11.23 12C8
YWHAZ tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta 
polypeptide
Terms/PE Signal transduction 8q23.1 4B6
Table 3: Genes induced in PE (Continued)BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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scripts, these membranes can also be useful for
characterizing either other biological systems, or the
effects of hypoxia on other tissues. The use of the SSH
approach to construct the membranes may also generate
some biases as the cloning is dependent on the existence
of Rsa1 restriction sites in the starting material (driver and
tester cDNAs). Nevertheless, our tool, focused on early
hypoxia, is a useful complement to other DNA arrays
experiments, based on commercial membranes [30]. As
shown in our study, this tool was used to analyze at the
mRNA level the consequences of the two most frequent
placental pathologies, preeclampsia and Intra-Uterine
Growth Retardation.
Some of the genes found associated with PE in the present
study had already been evaluated as putative markers of
placental pathological status, such as human chorionic
gonadotrophin (hCG) and human placental lactogen
(hPL, also known as CSHL1), as well as pregnancy specific
glycoproteins (PSGs). A significant serum increase in hCG
was found more prevalent in preeclamptic women [23].
In another recent study, hPL and PSGs were found
reduced at 17 weeks in the serum of patients who develop
later a preeclamptic condition, albeit serum levels are
restored later [31]. hCG is composed of two polypeptidic
chains,  α and β, encoded by CGA  (common to four
polypeptide hormones) and CGB, respectively. It is
known to play important roles in placental physiology
[32]. In our study CGA  was indeed found induced in
Non-random chromosomal clustering of genes highly expressed in the placenta Figure 6
Non-random chromosomal clustering of genes highly expressed in the placenta. Statistical analysis of intergenic distances 
revealed the existence of 8 clusters distributed on 7 chromosomes. The clusters located on 1q36, 11p15.5, 19q13 and 20q13 
are known to belong to imprinted chromosomal regions.BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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several PE cases, but could not be associated with a spe-
cific differential oxygen status. CGB was present in the
membranes, but was not specifically induced in preec-
lampsia. The only CGB clone was located in plate 7H12
(normoxia). The over-expression of CGA could lead to an
overall increase of hCG in the patient serum however the
mechanisms involved for regulating the expression of the
two polypeptidic chains constitutive of hCG seem to dis-
play opposite modes of regulation.
Recently, Bersinger and Odegard [31] have demonstrated
that in IUGR, hPL is continuously lowered later in preg-
nancy. This is consistent with our results, as we could not
detect any trace of expression of this gene in the IUGR
probes that were hybridized on the membranes. Similarly,
the expression level was low in control term placentas
(FTP). However, hPL appeared strongly induced in PE,
especially in severe cases. These results at the mRNA level
differ from the findings of Bersinger and Odegard [31]
concerning the hPL protein levels, which were going back
to normal at weeks 28 and 33 of preeclampsia. Possibly,
the accumulation of hPL mRNA would not be followed by
translation in PE.
Only three PSG were found in the membranes amongst
the 11 existing genes. PSGs are supposed to play an essen-
tial immunomodulatory effect in pregnancy [33-35].
Consistently with our result, in a recent microarray study
[36] the authors used a commercial membrane to identify
differentially expressed genes in preeclamptic and normal
placentas. Among the ten most highly expressed genes in
the membranes, the authors have identified PSG4, PSG5
and PSG7. Interestingly, those are exactly the highly
expressed genes that we have found in term placentas sug-
gesting that only these PSGs are specifically expressed at a
high level in term pregnancies. This observation raises the
question of the regulation of the entire cluster of PSG
genes which spans roughly 550 kilobases on 19q13 in the
order 3, 1, 6, 7, 11, 2, 5, 4, 9 (the precise localization of
the two other genes PSG 8 and PSG10 is not yet known).
To address the question of PSG regulation, we performed
a Clustal alignment of 3 kilobases upstream of the first
codons of PSG 1, 2, 3, 4, 5, 6, 7, 9, and 10. The clustering
of the promoters indicated a very high level of conserva-
tion and was not able to group PSG4, PSG5 and PSG7 as
more similar together (not shown). This indicates that the
specifically high expression level of 3 genes, which are not
Table 4: Genes induced in IUGR
Gene symbol Gene name Maximal 
signal
Protein category Chromosomal 
localization
Library 
address
16S ribosomal RNA 16S ribosomal RNA PE+IUGR Mitochondrial metabolism Mitochondria 14H2
BC014242 Hs.5064 IUGR 5 10C6
cDNA 
DKFZp686G03142
Homo sapiens mRNA; cDNA 
DKFZp686G03142
IUGR 5 16G12
COTL1 coactosin-like 1 (Dictyostelium) IUGR Structural protein 16q24.1 11A7
CUL4B cullin 4B IUGR Cell cycle Xq23 2D5
DAF decay accelerating factor for complement 
(CD55, Cromer blood group system)
IUGR Signal transduction 1q32 13G10
FEM1C fem-1 homolog c (C.elegans) IUGR+PE Transcription/Translation 5q22 8D9
FEM1C fem-1 homolog c (C.elegans) IUGR+PE Transcription/Translation 5q22 16D6
FTH1 ferritin, heavy polypeptide 1 IUGR Transport 11q13 20D12
FTH1 ferritin, heavy polypeptide 1 IUGR Transport 11q13 2G1
GLIPR1 GLI pathogenesis-related 1 (glioma) IUGR+PE 12q21.1 16G10
IMAGE:3453987 Homo sapiens cDNA clone IMAGE:3453987 IUGR 4 10C5
IGF2 Insulin-like growth factor 2 (somatomedin A) IUGR Growth factor 11p15.5 15E3
IMP-3 IGF-II mRNA-binding protein 3 IUGR Transcription/Translation/
Modification
7p11 18G10
KIAA1354 KIAA1354 protein IUGR Signal transduction 9p22 2D4
LOC285429 hypothetical protein LOC285429 IUGR 4p14 3B7
LOC374933 Homo sapiens LOC374933 (LOC374933), PE+IUGR 1p36.33 21G10
MGC2714 hypothetical protein MGC2714 PE+IUGR 11q22.2 13C7
ND1 NADH dehydrogenase subunit 2 IUGR Mitochondrial metabolism Mitochondria 15H1
PAPOLA poly(A) polymerase alpha IUGR Transcription/Translation/
Modification
14q32.31 10A7
SND1 staphylococcal nuclease domain containing 1 
EBNA2 coactivator p100
IUGR Transcription/Translation 7q31.3 2D4
TPI1 triosephosphate isomerase 1 IUGR Transport 12p13 8D2BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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contiguous, depends on specific long-range acting chro-
matin factors.
ANGPTL4, also called FIAF (fasting-induced adipose fac-
tor) is another 3 h hypoxia-activated gene recurrently
found in PE cases. It is a downstream target of PPARγ
(peroxisome-proliferator-activated receptor γ), and is
therefore supposed to regulate lipid metabolism and
glucose homeostasis [37]. Although belonging to a family
of 9 genes, it is the only one that we could detect by
hybridization, suggesting a highly specific mode of regu-
lation, consistently with what has been described of its
specific regulation compared to ANGPTL3 [38]. In mice,
ANGPTL4/FIAF is increased in the plasma by fasting and
decreased by high fat diet [39], demonstrating its involve-
ment in lipid capture in difficult physiological conditions,
of which PE may represent a paradigmatic case.
Another unexpected actor of the onset of PE could be H19.
This RNA-encoding gene is of ill-defined function. It is
located in the 11p15.5 cluster of imprinted genes and
expressed by the maternal allele, in apparent opposition
with IGFII. Both genes appear regulated by a common
DMR (differentially methylated region), and have oppo-
site effects on fetal growth in mice [20,40]. Both IGFII and
H19 were found in the set of hypoxia-induced genes, con-
sistently with the existence of HIF1α binding sites in their
promoters suggesting the ability to respond almost instan-
taneously to variations in oxygen concentration. For
IGFII, this is also consistent with its described although
controversed angiogenic properties [41,42]. However,
while IGFII was not PE-specific (and was found expressed
in term placentas, pathologic placentas (either PE or vas-
cular IUGR) as well as in early placentas exposed to
hypoxia),  H19  was specifically expressed in PE and
strongly in severe PE.
In our study, we could observe that true vascular IUGR
results in a drastic reduction of the transcriptional activity
of the placenta. In these cases, only mRNAs for IGFII,
PSG4,  PSG5  and  PSG7, and mitochondrial genes were
present, and no polyA could be detected. Therefore, we
could conclude that in vascular IUGR, only a minimal set
of genes was transcriptionnally maintained in the placen-
tal tissue in order to prevent spontaneous abortion, (i)
transcripts from genes of the respiratory cascade, (ii)
IGFII, one isoform of which is the essential growth factor
in placenta [20], and (iii) three genes of the PSG cluster.
The absence of polyA in the cDNAs from purely vascular
IUGR suggests that the remaining clones are maintained
by stabilization of the transcripts rather than at the tran-
scriptional level. This may be substantiated by the
observation of IMP3cDNA in the transcripts specifically
expressed in less severe cases of IUGR. IMP3 encodes a fac-
tor interacting with the IGFII mRNA, possibly stabilizing
the transcript, and belonging to an imprinted region on
chromosome 7.
In non-purely vascular IUGR, FTH1  (ferritin) was
expressed at a high level, suggesting the existence of
genetic adaptative mechanism to a restricted supply of
nutrients. However, ferritin was found twice in the library,
without correlation with the oxygen status, showing that
this gene does not participate directly in the rapid
response to low oxygen concentrations. Ferritin is a major
factor for ensuring a sufficient iron store to the neonate at
birth. This echoes to a study showing that children pre-
senting a low iron store at birth had low serum ferritin
concentrations at 9 months [43], suggesting a risk of iron
deficiency in the second postnatal year.
Interestingly, in both pathologies, we found the induction
of FEM1-C. This gene, discovered as a homologous of a
Caeborhabditis elegans gene contains KH domains, them-
selves highly present inside FGIF, the principal inducer of
the foetal globin. Again, its presence in the library was not
correlated with short hypoxia (3 h). However, we
observed that its mRNA concentration was lowered at 48
h hypoxia. Its occurrence in pathological situations could
refer to a specific adaptative mechanism aiming at increas-
ing the oxygen capture for the foetus. Its induction fits
well with the observed increase in ferritin mRNA, both
genes FEM1-C and FTH1, aiming at building the proteic
and prosthetic part of the globin polypeptide,
respectively.
Some particularly appealing genes for the diseases studied
were present in the membranes but were not revealed by
hybridization with specific pathologic samples, as they
appear down-regulated in pathological conditions.
Among those, we found two clones corresponding to
SERPINE2 and one to SERPING1. These two genes are
inhibitors of Serine-Proteases that may play a role in
thrombus clearance, and therefore are necessary for ade-
quate circulatory functions. SERPING1  (also known as
C1-inhibitor) is particularly interesting, since several
mutations of this gene are involved in the development of
hereditary angioedema (MIM&606860, [44-47]). Oede-
mas frequently accompanies the preeclamptic condition,
therefore specific malfunctions of SERPINE2  and
SERPING1 could represent risk factors for placental dis-
eases. SERPINE2 also appeared in our previous study [18]
as a gene present in the hypoxic library at the highest
number of occurrences. Therefore, it suggests that a gene
induced by short-term hypoxia, may be on the contrary
down-regulated by chronic hypoxia, such as observed in
PE. Recently, we have shown that the same type of
regulation is also true for SERPING1 (F. Quetin and S. T
Chelbi, unpublished results).BMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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We performed a systematic analysis of the 5' regions of the
PE and IUGR induced genes. In many of them, we found
CpG islands that may be modulators of gene expression.
In a future work we shall analyze several of these regions
by bisulphite analysis of CpG methylation in normal and
pathological cases, to try to give a molecular basis to the
observed differences in gene expression. In most cases, we
discovered more than one HIF binding site in the various
promoters identified. Experimental verification will be
needed to evaluate the significance of these binding sites.
A surprising result in our study was the demonstration
that genes expressed at a level sufficiently high to be
detectable in one at least of our hybridization experi-
ments, are mapped to specific chromosome regions. This
is particularly the case for clusters of imprinted genes. In
these respects, the involvement of the 11p15.5 cluster in
the physiopathology of PE fits well with the recent obser-
vation that the invalidation of p57/kip2, another gene of
this cluster results in "preeclampsia-like" symptoms in
mice [48].
In recent studies, several groups have demonstrated that
the human genome is organized in large clusters of highly
expressed genes [49,50]. This high level organization of
the human genome is conserved in other mammalian spe-
cies, such as cattle and pigs [51]. In the present study, we
demonstrate that beside expression level, clustering also
exists for functional purposes, such as placental physiol-
ogy. This vision of the mammalian genome is consistent
with the hypotheses and experimental demonstrations
developed by Cremer and co-workers, indicating that the
presence of entire chromosomes or chromosome regions
inside sub-compartments of the nucleoplasm triggers var-
iations in expression levels [52].
Conclusion
In conclusion, our study has:
• Demonstrated highly significant differences between
isolated IUGR and PE concerning the effects of placental
oxygen pressure on gene expression. This finding suggests
that very different mechanisms are involved when IUGR
originates from a fetus-borne developmental dysfunction,
and when IUGR results from a vascular defect such as PE.
• Provided the scientific community with a directly avail-
able tool, making the link between hypoxia and placental
diseases
• Confirmed the importance of several risk factors for PE
and IUGR (such as CGA, PSGs and hPL)
• Suggested new possible targets for diagnosing early these
pathologies, and possibly for alleviating their effects (such
as COX1, ANGPTL4, H19, FTH1, FEM1c, IMP3, SERPING1
and SERPINE2). Since the SSH was carried out from an
early placenta, our study makes the link between potential
markers of early oxygen depletion, and the late develop-
ment of preeclamptic lesions, strengthening the idea that
PE may be caused by early alterations of placental
function.
• Demonstrated the existence of a genomic organization
of placental function in placental mammals.
This work opens the way to characterize at the molecular
level the physio-pathological mechanisms of very com-
plex situations that often perturb normal pregnancies.
Methods
Patients and ethics
All the placentas from the patients were collected from
four Parisian maternities (Cochin, St Antoine, Institut de
Puériculture and St Vincent de Paul). This study was
approved by the Ethics Committee of Paris Cochin
(France), CCPPRB (Comité Consultatif de Protection des
Personnes dans la Recherche Biomédicale). All the
patients have given their written consent for the use of
their placenta. Early term placentas (ETP) were obtained
from healthy women undergoing legal abortion by vac-
uum curettage between 8 and 12 weeks of amenorrhea.
"Late" placentas were obtained from caesarean section
outside labor from healthy mothers ("FTP or Full-Term
Placenta", between 38 and 39 weeks of amenorrhea) or
from mothers with pathological pregnancies ("PE" or
"IUGR", between 28 and 37 weeks of amenorrhea). The
details about the patients used are given on Table 1.
Placental villi from term placentas (control and 
pathological)
Biopsy samples were rapidly collected at six to ten various
locations from each placenta between the decidual and
chorionic plates. Villous tissue was dissected free of fetal
membranes, vessels and tissue from maternal origin,
rinsed and minced in Ca2+, Mg2+ free Hank's Balanced Salt
Solution (HBSS).
Placental villi from early placentas and hypoxia conditions
Floating villi isolated by fine mechanical dissection were
cleaned in order to remove fetal membranes, large vessels
and tissue from maternal origin. They were rinsed and
minced in Ca2+, Mg2+ free Hank's Balanced Salt Solution
(HBSS). They were plated on 60 mm diameter dishes (0.4
g villi/dish) in 3 ml of RPMI 1640 medium supplemented
with 10% (V/V) fetal bovine serum, 25 mM HEPES, 2 mM
glutamine and antibiotics (100 IU/ml penicillin and 100
µg/ml streptomycin). They were made hypoxic by placing
them in a Lwoff chamber at 37°C and exposed to an oxy-
gen-depleted atmosphere (2% O2, 5% CO2, 93% N2) orBMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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maintained at 37°C in normal conditions in humidified
5%CO2-95% air during 3 or 48 h. The hypoxia was con-
trolled by checking the atmospheric oxygen pressure at
the end of the experiment using an ABL725 gas analyzer
(Radiometer, Copenhagen) as previously described exten-
sively [18]).
After incubation or alternatively, directly after dissection,
villi from either early or term placentas were dry-frozen in
Trizol™ reagent (Life Technologies, Cergy, France) for
RNA isolation, and store at -80°C until processed.
RNA isolation, Poly-A+ preparation, cDNA synthesis and 
Subtraction experiment
For the SSH experiment [53], the starting material was
constituted by villi from a 11 week normal placenta. After
dissection, 2 batches of 2 g of villi from different zones of
the placenta were cultured for 3 h either in hypoxic or nor-
moxic conditions. Total RNA was extracted from villous
tissue using Trizol™ reagent according to the method of
Chomczynski and Sacchi [54]. PolyA+ RNAs were then
fractionated from total RNA on Oligo dT latex beads using
Macherey-Nagel columns (Macherey-Nagel, Germany).
cDNA were synthesized from 1.5 – 2 µg of polyA+ using
the reverse transcriptase of the cDNA-select kit (PCR-
Select cDNA Subtraction Kit, CLONTECH). Linkers were
ligated to one batch of each sample ("tester") and hybrid-
ized with an excess of the other sample ("driver") using
two consecutive hybridization steps. The products
obtained are then amplified by PCR using two nested
primers present in the linkers. After the SSH procedure,
two effects are expected to happen on the cDNAs: firstly, a
normalization that reduces drastically the number of mol-
ecules corresponding to highly abundant mRNA species,
and secondly, a subtraction which enriches considerably
each "tester" in tester-specific molecules, i.e. molecules
that were initially rare in the "driver". The experiment was
then performed by following accurately the manufac-
turer's advices, and performing all the possible controls at
each step. The normalization was monitored by measur-
ing the GAPDH level by quantitative RT-PCR in the SSH
product versus a mock-subtracted sample. In our case, we
could show that the normoxia specific product (called "N-
H") was roughly depleted 4,000 times in GAPDH, while
the hypoxia-specific product (called "H-N") was depleted
around 3,000 times in GAPDH. The quality of the
subtraction was evaluated by RT-PCR using primers for
the Vascular Endothelial Growth Factor (VEGF) (sense: 5'-
ATGAACTTTCTGCTGTCTTGGGTG-3' and antisense: 5'-
CTCACCGCCTCGGCTTGTCAC-3'), this gene being
highly induced in hypoxic condition. While a band was
clearly detectable after 25 PCR cycles in the hypoxia versus
normoxia SSH product, no signal could be seen after 40
PCR cycles in the normoxia versus hypoxia SSH product
(not shown).
Library construction and spotting on high-density 
macroarrays
The secondary PCR product (nested PCR at the end of
each subtraction) was cloned in pGEMT vector (Promega
corp.), by incubating 300 ng of each of the PCR products
with 50 ng of vector with T4 DNA ligase (Biolabs) and the
appropriate buffer during 48 h at 4°C, in a total volume
of 20 µl. The ligations were diluted to the fifth in sterile
water and used to transform DH10B electrocompetent E.
coli bacteria using a Biolabs electroporator. The transfor-
mation titre was evaluated on 8 cm LB-agar plates
prepared with 100 µg/ml ampicillin and IPTG/XGal [55],
and the next day ~1500 colonies from each of the two
subtractions were plated on 22 cm × 22 cm LB-agar trays.
After an overnight growth, the colonies were manually
picked (864 from the N-H library and 1440 from the H-N
library) and grown individually in 96-well mega plates
containing 1 ml LB/100 µg/ml ampicillin and 10% glyc-
erol. The plates were covered with porous covers and
grown overnight at 37°C under rocking at 200 rpm. Part
of the culture was stored at -80°C and 200 µl were trans-
ferred to Genetix™ 96-well plates and used by a robotic
station for double-spotting on nylon membranes
(Hybond N+, Amersham) overlaying new LB-agar/ampi-
cillin trays. The cultures were grown overnight on the
membranes at 37°C and the DNA was prepared in situ by
three consecutive incubations in NaOH 0.5 M (20 min.),
Tris-Cl 1.5 M (10 min.), pH 7.5 and SSC 2X (10 min.).
Then, the DNA was fixed to the membranes by UV-light
irradiation during 5 min (304 nm).
Probes, Probe labelling and Hybridizations
Early placentas around 11 weeks (2 hybridizations), early
placentas exposed to an hypoxic environment during 48
hours (2 hybridizations), or term placentas from normal
(3 hybridizations, out of which one correspond to a mix-
ture of 6 term cDNAs) and pathological states placenta
(10 PE, 2 PE+IUGR, 3 IUGR, one of which was a mixture
of 2 IUGR were hybridized to two sets of membranes. As
the clones were spotted in duplicates, each hybridization
resulted in four positive signals for an expressed gene.
Probes were synthesized from 4 µg of total RNA by ran-
dom hexanucleotide priming, using 20 µM of primers in
the presence of Moloney Murine Leukemia Virus Reverse
Transcriptase (MMLV) in a total volume of 25 µl at 39°C
according to the manufacturer's specifications (Life Tech-
nologies). The cDNA products were stored at -20°C until
required for probe labelling. Labelling was performed
with 50 ng of cDNA and 5 µl α33P dATP using the Biolabs
Klenow labelling kit, and allowing the reaction to last dur-
ing four hours, following the manufacturer's recommen-
dations for 33P labelled nucleotides. The ratio of
radiolabeled nucleotide incorporation was evaluated by
counting before and after TCA precipitation, and was sys-
tematically close to 80% [55]. Hybridizations wereBMC Genomics 2005, 6:111 http://www.biomedcentral.com/1471-2164/6/111
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performed overnight with a standardized amount of radi-
olabelled probe, in a hybridization oven at 42°C in the
following buffer: SSC 4X, Denhardt's 2.5X, SDS, 0.5%,
Tris HCL-EDTA (10 mM-1 mM, pH 7.5), Dextran sulfate
1 g/10 ml. The membranes were then washed three times
at 58°C in 2X SSC, wrapped in Saran™ and autoradio-
graphed overnight.
Sequencing
Addresses of positive clones were identified from the
autoradiography and the corresponding colonies were
grown overnight in 3 ml LB/ampicillin. After overnight
growth at 37°C, with a 200 rpm circular agitation, the
plasmids were miniprepped according to classical proto-
cols. The cDNA concentration was evaluated after running
on an Ethidium Bromide-stained 1% agarose gel, and 600
ng were sequenced using a 16-capillar Applied Biosystem
sequencing machine, using an Applied Biosystem
sequencing kit.
Quantification of the signals and statistical analysis
Each signal was quantified by densitometry using the
Scion software [56]. Data were entered in an Excel table
encompassing 2304 rows and one column for each signal
obtained in a hybridization experiment. Data were nor-
malized by reference to a maximum signal intensity fixed
at 120 (arbitrary units). They were then grouped into six
categories corresponding to the averages of the hybridiza-
tion experiments, ETP (Early Term Placenta) ETP48 h
(Early Term Placenta maintained 48 h at 2% O2), FTP
(Control Full Term Placenta), PE (Preeclampsia), R (Intra-
Uterine Growth retardation), PER (Preeclampsia and Intra
Uterine Growth Retardation). Data were then clustered in
a hierarchical tree using the software developed by Eisen
and coworkers, Cluster and Treeview, available at [22,57].
The program Cluster was used after the following data
preparation: median centering and normalization of
genes and arrays, before launching the "complete cluster-
ing" procedure. The distribution of groups of genes
expressed in only one situation, was analyzed in relation
to expected distribution in the normoxic/hypoxic plates of
clones (plates 1 to 9 resulted from the normoxia –
hypoxia subtraction, while plates 10 to 24 resulted from
hypoxia – normoxia subtraction. The distributions could
therefore be tested by a Chi2 analysis.
A simple mathematical method was implemented for pro-
filing the CpG islands present in the promoters of the
genes identified. Briefly, all the CpG positions were iden-
tified in the 5 kb upstream of transcription initiation start
site for each gene, and the distance between two consecu-
tive CpG was computed. Then, a mobile average was com-
puted for sliding windows corresponding to ten
consecutive CpG islands. A CpG density was estimated at
each position by dividing 1000 by the average of each slid-
ing window, resulting in the number of CpG per kilobases
of DNA.
To study statistically the chromosomal distribution of the
highly expressed subset of placental genes from the mac-
roarrays, we evaluated the size of the minimal statistically
significant interval expected to contain 2, 3, 4, 5, 6, 7 or 8
genes. This was calculated using a Binomial law with 2 to
8 successes amongst 276 trials, with a probability of suc-
cess being estimated as the size of the interval divided by
the genome size (3000 megabases; in this study, the gene
distribution was supposed to be similar for each chromo-
some, which is an approximation since some chromo-
somes are gene-rich and some others are gene-poor). The
probabilities were corrected by the Bonferroni correction,
available at [58] for multiple testing, assuming 276 inde-
pendent tests. Using this procedure, the minimal signifi-
cant genomic interval sizes could be estimated at 0.21,
1.18, 3.05, 5.70, 9.05, 13.0 and 17.30 Mb for 2, 3, 4, 5, 6,
7, or 8 genes respectively (The complete set of data is
available upon request).
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